Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Search results for

There are 22,215 results that match your search.22,215 results
  • A number of pharmaceutical companies in Mexico recently faced an unpleasant situation in public tender proceedings. Alejandro Luna of Olivares & Cia explains how patent owners can protect their rights before the countries’ struggling health authorities
  • Until recently, a loophole in Mexico's patent law allowed generic companies to gain marketing approval for drugs still under patent. Oscar M Becerril of Becerril Coca & Becerril in Mexico City examines attempts to fix the problem
  • Taking a global approach to business creates new challenges for any company. Chris Cabou, general counsel of GE Global Reseach, tells Sam Mamudi how he handles a team that stretches across three continents
  • In cases of North American cross-border infringement, IP owners should think before instinctively launching action in the US. Andrew M Shaughnessy and Andrew E Bernstein of Torys in Toronto explore the costs and benefits of seeking redress in Canada's courts
  • At a time when international IP litigation seems like a web of ever-increasing possibilities, mediation and arbitration are emerging as credible alternatives. Stéphanie Bodoni discovers a possibly ideal, but seemingly long-ignored ADR forum and finds out why it has taken so long for cases to get there
  • Jim Mendenhall, Assistant US Trade Representative for Services, Investment and Intellectual Property
  • Australia's IP regime hit the headlines this year when politicians passed legislation to implement the Australia-US free trade agreement. More changes were introduced by the Designs Act 2003, a new law that came into force in June 2004 and introduced long overdue reforms to Australia’s design rules. David Webber, Victor Tse and Raymond Hind explain more
  • Biotechnology has become one of the most important areas of science for the 21st century. Justin Davidson, Connie Carnabuci and Grace Tan consider the potential for developing and promoting biotechnology in Asia, focusing in particular on China - one of the most important emerging economies in Asia
  • With no central patent court in sight, Europe’s litigation system will continue to be a confusing, expensive and challenging maze of possibilities. Big multinationals have to deal with it and have developed specific strategies to enforce their patents. Stéphanie Bodoni examines their tactics
  • Argentina's reforms have been met with approval by the patent community. Martín Bensadon and Ignacio Sánchez Echagüe explain what the changes mean to patent holders